Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars

    Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars

    FromBioSpace

    Start listeningView podcast show

    Sweet succession: Gonzalez, patent thickets and his triumph over biosimilars

    FromBioSpace

    ratings:
    Length:
    14 minutes
    Released:
    Feb 28, 2024
    Format:
    Podcast episode

    Description

    This week Lori, Greg and Tyler discuss AbbVie: how longtime CEO Richard Gonzalez navigated Humira's LOE, his victorious retirement announcement, and the future of biosimilars.
    Also discussed: Earlybird Health's $186m VC fund; and definitely not the IRA.
    Released:
    Feb 28, 2024
    Format:
    Podcast episode

    Titles in the series (46)

    Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.